Dow Chemical's strategic move towards specialty chemicals "isn't a question of the risk we took but what we would have suffered if we didn't," said Dow CEO Andrew Liveris in this interview, referring to the company's move away from commodity chemicals. Liveris has led a new direction for Dow, as the company bought specialty chemicals maker Rohm & Haas for $15 billion in 2008 and has turned initial negative response to the deal into a bright and productive prospect for the company.

Full Story:

Related Summaries